- Home
- CGEN vs GORO Comparison
CGEN vs GORO Comparison
Compare CGEN & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- GORO
- Stock Information
- Founded
- CGEN 1993
- GORO 1998
- Country
- CGEN Israel
- GORO United States
- Employees
- CGEN 74
- GORO N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- GORO Precious Metals
- Sector
- CGEN Health Care
- GORO Basic Materials
- Exchange
- CGEN Nasdaq
- GORO Nasdaq
- Market Cap
- CGEN 125.3M
- GORO 105.7M
- IPO Year
- CGEN 2000
- GORO N/A
- Fundamental
- Price
- CGEN $1.38
- GORO $0.81
- Analyst Decision
- CGEN
- GORO Strong Buy
- Analyst Count
- CGEN 0
- GORO 2
- Target Price
- CGEN N/A
- GORO $1.38
- AVG Volume (30 Days)
- CGEN 238.3K
- GORO 2.7M
- Earning Date
- CGEN 11-11-2025
- GORO 11-04-2025
- Dividend Yield
- CGEN N/A
- GORO N/A
- EPS Growth
- CGEN N/A
- GORO N/A
- EPS
- CGEN N/A
- GORO N/A
- Revenue
- CGEN $22,144,000.00
- GORO $49,824,000.00
- Revenue This Year
- CGEN N/A
- GORO N/A
- Revenue Next Year
- CGEN $159.40
- GORO $117.97
- P/E Ratio
- CGEN N/A
- GORO N/A
- Revenue Growth
- CGEN N/A
- GORO N/A
- 52 Week Low
- CGEN $1.13
- GORO $0.12
- 52 Week High
- CGEN $2.66
- GORO $0.87
- Technical
- Relative Strength Index (RSI)
- CGEN 41.92
- GORO 70.70
- Support Level
- CGEN $1.39
- GORO $0.70
- Resistance Level
- CGEN $1.47
- GORO $0.87
- Average True Range (ATR)
- CGEN 0.06
- GORO 0.07
- MACD
- CGEN -0.00
- GORO 0.03
- Stochastic Oscillator
- CGEN 33.33
- GORO 86.38
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.